NDC properties for "Retacrit" (RxCUI 2463733)
About this data
The tables show NDC propoerties for Retacrit with the RxCUI 2463733
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Retacrit (RxCUI 2463733)
| BLA | BLA125545 |
|---|---|
| MMSL_CODE | BD37279 |
| RxCUI | 2463733 |
| SPL_SET_ID | 3af26b0d-8ad0-44e1-a538-8bdb5ab39374 |
| SPL_SET_ID | e6e4dd0c-25ca-40b2-ba6b-6138a68621fe |
| Prescribable Synonym | Retacrit 10,000 UNT/ML Injectable Solution |
| RXNAV_STR | Retacrit 10000 UNT/ML Injectable Solution |
| RxNorm Name | epoetin alfa-epbx 10000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | EPO-epbx 10000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | ERYTHROPOIETIN-epbx 10000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | Retacrit (epoetin alfa-epbx 20,000 UNT per 2 ML) Injectable Solution |
| RxNorm Synonym | Retacrit 10000 UNT/ML Injectable Solution |
| Related queries | Interactions (for RxCUI 2463733) |
NDC Properties
NDC Item 00069131801
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-01 |
| NDC Item | 00069131801 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131804
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-04 |
| NDC Item | 00069131804 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131810
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-10 |
| NDC Item | 00069131810 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 59353022001
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-01 |
| NDC Item | 59353022001 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 59353022010
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-10 |
| NDC Item | 59353022010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 00069131801
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-01 |
| NDC Item | 00069131801 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131804
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-04 |
| NDC Item | 00069131804 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131810
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-10 |
| NDC Item | 00069131810 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 59353022001
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-01 |
| NDC Item | 59353022001 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 59353022010
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-10 |
| NDC Item | 59353022010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 00069131801
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-01 |
| NDC Item | 00069131801 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131804
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-04 |
| NDC Item | 00069131804 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131810
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-10 |
| NDC Item | 00069131810 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 59353022001
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-01 |
| NDC Item | 59353022001 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 59353022010
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-10 |
| NDC Item | 59353022010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 00069131801
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-01 |
| NDC Item | 00069131801 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131804
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-04 |
| NDC Item | 00069131804 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131810
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-10 |
| NDC Item | 00069131810 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 59353022001
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-01 |
| NDC Item | 59353022001 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 59353022010
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-10 |
| NDC Item | 59353022010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 00069131801
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-01 |
| NDC Item | 00069131801 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131804
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-04 |
| NDC Item | 00069131804 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-04) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 00069131810
| NDC 9 | 0069-1318 |
|---|---|
| NDC 10 | 0069-1318-10 |
| NDC Item | 00069131810 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1318 |
NDC Item 59353022001
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-01 |
| NDC Item | 59353022001 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |
NDC Item 59353022010
| NDC 9 | 59353-220 |
|---|---|
| NDC 10 | 59353-220-10 |
| NDC Item | 59353022010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-220-10) / 2 mL in 1 VIAL, MULTI-DOSE (59353-220-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-220 |